{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:46:20Z","timestamp":1785242780025,"version":"3.55.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,4]]},"DOI":"10.7759\/cureus.91599","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T13:27:21Z","timestamp":1756992441000},"source":"Crossref","is-referenced-by-count":2,"title":["Posterior Reversible Encephalopathy Syndrome Potentially Associated With Erythropoietin Analogs: A Case Report"],"prefix":"10.7759","author":[{"given":"Ayman","family":"Shaat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avinash K","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s13760-016-0703-5","article-title":"Predictors of intensive care unit utilization in patients with posterior reversible encephalopathy syndrome","volume":"117","author":"Hinduja A","year":"2017","unstructured":"Hinduja A, Habetz K, Raina SK, Fitzgerald RT. Predictors of intensive care unit utilization in patients with posterior reversible encephalopathy syndrome. Acta Neurol Belg. 2017, 117:201-6. 10.1007\/s13760-016-0703-5","journal-title":"Acta Neurol Belg"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/NRL.0000000000000309","article-title":"Erythropoietin-associated posterior reversible encephalopathy syndrome","volume":"26","author":"White JD","year":"2021","unstructured":"White JD, Anne M, Muralidharan R. Erythropoietin-associated posterior reversible encephalopathy syndrome. Neurologist. 2021, 26:98-100. 10.1097\/NRL.0000000000000309","journal-title":"Neurologist"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A0549","article-title":"Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome","volume":"28","author":"Bartynski WS","year":"2007","unstructured":"Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2007, 28:1320-7. 10.3174\/ajnr.A0549","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omx011","article-title":"Posterior reversible encephalopathy syndrome (PRES)","volume":"2017","author":"Sudulagunta SR","year":"2017","unstructured":"Sudulagunta SR, Sodalagunta MB, Kumbhat M, Settikere Nataraju A. Posterior reversible encephalopathy syndrome (PRES). Oxf Med Case Reports. 2017, 2017:omx011. 10.1093\/omcr\/omx011","journal-title":"Oxf Med Case Reports"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7860\/JCDR\/2019\/40900.12748","article-title":"Postpartum haemolytic uremic syndrome (PHUS) with posterior reversible encephalopathy syndrome (PRES) complicating pregnancy: a rare case report","volume":"13","author":"Bhatia A","year":"2019","unstructured":"Bhatia A, Bhagwat A, Acharya S, Acharya N, Bhawane A. Postpartum haemolytic uremic syndrome (PHUS) with posterior reversible encephalopathy syndrome (PRES) complicating pregnancy: a rare case report. JCDR. 2019, 13: OD01-3. 10.7860\/JCDR\/2019\/40900.12748","journal-title":"JCDR"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-7176.2008.07758.x","article-title":"Secondary hypertension: interfering substances","volume":"10","author":"Grossman E","year":"2008","unstructured":"Grossman E, Messerli FH. Secondary hypertension: interfering substances. J Clin Hypertens (Greenwich). 2008, 10:556-66. 10.1111\/j.1751-7176.2008.07758.x","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.49.3.686","article-title":"Erythropoietin-associated hypertensive posterior leukoencephalopathy","volume":"49","author":"Delanty N","year":"1997","unstructured":"Delanty N, Vaughan C, Frucht S, Stubgen P. Erythropoietin-associated hypertensive posterior leukoencephalopathy. Neurology. 1997, 49:686-9. 10.1212\/wnl.49.3.686","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-020-00932-1","article-title":"Posterior reversible encephalopathy syndrome","volume":"25","author":"Gewirtz AN","year":"2021","unstructured":"Gewirtz AN, Gao V, Parauda SC, Robbins MS. Posterior reversible encephalopathy syndrome. Curr Pain Headache Rep. 2021, 25:19. 10.1007\/s11916-020-00932-1","journal-title":"Curr Pain Headache Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00111-8","article-title":"Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions","volume":"14","author":"Fugate JE","year":"2015","unstructured":"Fugate JE, Rabinstein AA. Posterior reversible encephalopathy syndrome: clinical and radiological manifestations, pathophysiology, and outstanding questions. Lancet Neurol. 2015, 14:914-25. 10.1016\/S1474-4422(15)00111-8","journal-title":"Lancet Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0044534","article-title":"Determinants of recovery from severe posterior reversible encephalopathy syndrome","volume":"7","author":"Legriel S","year":"2012","unstructured":"Legriel S, Schraub O, Azoulay E, et al.. Determinants of recovery from severe posterior reversible encephalopathy syndrome. PLoS One. 2012, 7:e44534. 10.1371\/journal.pone.0044534","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5698\/1535-7511-15.6.317","article-title":"PRES-ing for answers about long-term seizure risk in patients with posterior reversible encephalopathy syndrome: PRES-ing for answers about long-term seizure risk","volume":"15","author":"Spencer D","year":"2015","unstructured":"Spencer D. PRES-ing for answers about long-term seizure risk in patients with posterior reversible encephalopathy syndrome: PRES-ing for answers about long-term seizure risk. Epilepsy Curr. 2015, 15:317-8. 10.5698\/1535-7511-15.6.317","journal-title":"Epilepsy Curr"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-011-6362-9","article-title":"Posterior reversible encephalopathy syndrome (PRES): electroencephalographic findings and seizure patterns","volume":"259","author":"Kastrup O","year":"2012","unstructured":"Kastrup O, Gerwig M, Frings M, Diener HC. Posterior reversible encephalopathy syndrome (PRES): electroencephalographic findings and seizure patterns. J Neurol. 2012, 259:1383-9. 10.1007\/s00415-011-6362-9","journal-title":"J Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/397191-posterior-reversible-encephalopathy-syndrome-potentially-associated-with-erythropoietin-analogs-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T13:27:22Z","timestamp":1756992442000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/397191-posterior-reversible-encephalopathy-syndrome-potentially-associated-with-erythropoietin-analogs-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.91599","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,4]]}}}